Home LiteratureArticle Details
PMID: 19203090 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

The beta cell population in type 1 diabetes.

Novartis Foundation symposium ·Vol. 292 ·2008-00-00 ·Pages 19-24; discussion 24-31, 122-9, 202-3

Pipeleers D, In't Veld P, Pipeleers-Marichal M, Gorus F

Abstract

Type 1 diabetes is often considered as a disease where more than 90% of the beta cells have been destroyed at clinical onset and where beta cell antigen-driven autoimmune reactivities progressively destroy remaining beta cells as well as newly formed or implanted beta cells. This view will be evaluated in light of histological observations in the pancreas of type 1 diabetic patients and of antibody-positive non-diabetic organ donors.

MeSH Terms
Autoantibodies/immunology,metabolism Cell Survival Diabetes Mellitus, Type 1/immunology,pathology Histocompatibility Antigens Class I/immunology,metabolism Humans Insulin-Secreting Cells/immunology,metabolism,pathology Lymphocytes/immunology
Chemicals
Autoantibodies Histocompatibility Antigens Class I
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Pipeleers Daniel
Diabetes Research Center at Brussels Free University-VUB, JDRF Center for Beta Cell Therapy in Diabetes, Laarbeeklaan 103, 1090 Brussels, Belgium.
In't Veld Peter
Pipeleers-Marichal Miriam
Gorus Frans
Article Info
Journal
Novartis Foundation symposium
Abbr.
Novartis Found Symp
ISSN
1528-2511
Published
2008-00-00
Pages
19-24; discussion 24-31, 122-9, 202-3
Language
English
Region
England
NLM ID
9807767
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com